{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:43:40Z","timestamp":1793317420968,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal Office of Public Health"},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation (SNSF)","doi-asserted-by":"publisher","award":["IZK0Z3_171414"],"award-info":[{"award-number":["IZK0Z3_171414"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation (SNSF)","doi-asserted-by":"publisher","award":["P3SMP3_155315"],"award-info":[{"award-number":["P3SMP3_155315"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss Foundation for Grants in Biology and Medicine (SFGBM)"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.02.010","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T04:30:54Z","timestamp":1488861054000},"page":"1946-1953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-2118","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Allemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal M.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio D.","family":"Brugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hilty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"363","key":"10.1016\/j.vaccine.2017.02.010_b0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(04)15495-0","article-title":"Otitis media","volume":"7","author":"Rovers","year":"2004","journal-title":"Lancet"},{"issue":"26 Suppl 7","key":"10.1016\/j.vaccine.2017.02.010_b0010","doi-asserted-by":"crossref","first-page":"G2","DOI":"10.1016\/j.vaccine.2008.11.005","article-title":"The burden of otitis media","volume":"23","author":"Rovers","year":"2008","journal-title":"Vaccine"},{"issue":"208","key":"10.1016\/j.vaccine.2017.02.010_b0015","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/infdis\/jit289","article-title":"Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution","volume":"1","author":"Dagan","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.010_b0020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"59","key":"10.1016\/j.vaccine.2017.02.010_b0025","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/ciu683","article-title":"Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent\/13-valent PCV","volume":"15","author":"Ben-Shimol","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.010_b0030","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden","volume":"47","author":"Galanis","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2017.02.010_b0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1185\/03007995.2015.1119676","article-title":"Indirect effects of a 7year PCV7\/PCV13 mass vaccination program in children on the incidence of pneumonia among adults: a comparative study based on two Polish cities","volume":"32","author":"Patrzalek","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"29","key":"10.1016\/j.vaccine.2017.02.010_b0040","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1016\/j.vaccine.2011.08.057","article-title":"Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US","volume":"19","author":"Shea","year":"2011","journal-title":"Vaccine"},{"issue":"344","key":"10.1016\/j.vaccine.2017.02.010_b0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"8","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.02.010_b0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2431-9-14","article-title":"Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination","volume":"9","author":"Mackenzie","year":"2009","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.vaccine.2017.02.010_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/INF.0b013e318159228f","article-title":"Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants","volume":"27","author":"O'Brien","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.02.010_b0060","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/cid\/cis292","article-title":"Impact of pneumococcal conjugate vaccination on otitis media: a systematic review","volume":"54","author":"Taylor","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"32","key":"10.1016\/j.vaccine.2017.02.010_b0065","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.vaccine.2014.07.060","article-title":"Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study","volume":"8","author":"Meichtry","year":"2014","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2017.02.010_b0070","first-page":"12","article-title":"Serotype\/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014","volume":"26","author":"Hauser","year":"2016","journal-title":"Eurosurveillance"},{"issue":"187","key":"10.1016\/j.vaccine.2017.02.010_b0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1086\/367994","article-title":"Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998\u20131999","volume":"15","author":"Muhlemann","year":"2003","journal-title":"J Infect Dis"},{"issue":"145","key":"10.1016\/j.vaccine.2017.02.010_b0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0025-5564(97)00014-X","article-title":"An age-structured model for pertussis transmission","volume":"15","author":"Hethcote","year":"1997","journal-title":"Math Biosci"},{"key":"10.1016\/j.vaccine.2017.02.010_b0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00005537-200403000-00031","article-title":"Epiglottitis in the Hemophilus influenzae type B vaccine era: changing trends","volume":"114","author":"Shah","year":"2004","journal-title":"Laryngoscope"},{"issue":"33","key":"10.1016\/j.vaccine.2017.02.010_b0090","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1016\/j.vaccine.2015.08.022","article-title":"Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom","volume":"22","author":"Lau","year":"2015","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2017.02.010_b0095","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1016\/j.vaccine.2015.08.010","article-title":"A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation","volume":"22","author":"Cohen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.010_b0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00431-014-2409-0","article-title":"Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany","volume":"174","author":"van der Linden","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"32","key":"10.1016\/j.vaccine.2017.02.010_b0105","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England","volume":"23","author":"van Hoek","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.02.010_b0110","first-page":"350","article-title":"Impact of vaccination on acute otitis media","volume":"17","author":"Blanchard-Rohner","year":"2016","journal-title":"Rev Med Suisse"},{"issue":"34","key":"10.1016\/j.vaccine.2017.02.010_b0115","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.vaccine.2016.02.045","article-title":"The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduction","volume":"29","author":"Nunes","year":"2016","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2017.02.010_b0120","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1016\/j.vaccine.2013.04.074","article-title":"Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogota, Colombia","volume":"20","author":"Parra","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.010_b0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21645515.2015.1095414","article-title":"Pneumococcal nasopharyngeal carriage in children \u22175 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel","volume":"12","author":"Ben-Shimol","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.02.010_b0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/INF.0b013e318194e783","article-title":"Epidemiologic and microbiologic characteristics of culture-positive spontaneous otorrhea in children with acute otitis media","volume":"28","author":"Leibovitz","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.02.010_b0135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/INF.0b013e31821038d9","article-title":"The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea","volume":"30","author":"Stamboulidis","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.02.010_b0140","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1473-3099(15)00549-6","article-title":"Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease","volume":"16","author":"Dagan","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2017.02.010_b0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/380642","article-title":"Association of clinical signs and symptoms with bacterial findings in acute otitis media","volume":"15","author":"Palmu","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.010_b0150","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.010_b0155","doi-asserted-by":"crossref","first-page":"e1003868","DOI":"10.1371\/journal.pgen.1003868","article-title":"Dominant role of nucleotide substitution in the diversification of serotype 3 pneumococci over decades and during a single infection","volume":"9","author":"Croucher","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.vaccine.2017.02.010_b0160","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2009-3027","article-title":"Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers","volume":"126","author":"Yeh","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.02.010_b0165","doi-asserted-by":"crossref","first-page":"e11638","DOI":"10.1371\/journal.pone.0011638","article-title":"Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine","volume":"5","author":"Brugger","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.02.010_b0170","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1128\/JCM.01877-08","article-title":"Detection of Streptococcus pneumoniae strain cocolonization in the nasopharynx","volume":"47","author":"Brugger","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"34","key":"10.1016\/j.vaccine.2017.02.010_b0175","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1016\/j.vaccine.2016.06.017","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage","volume":"25","author":"Valente","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.010_b0180","doi-asserted-by":"crossref","first-page":"e30235","DOI":"10.1371\/journal.pone.0030235","article-title":"Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine","volume":"7","author":"Valente","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.02.010_b0185","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/infdis\/jis024","article-title":"Nasopharyngeal microbiota in infants with acute otitis media","volume":"205","author":"Hilty","year":"2012","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T15:58:41Z","timestamp":1535990321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":37,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17301743"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}